Press Release Archive
Press Releases
February 2024
02.29.2024 Financial Investments Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
December 2023
12.14.2023 Corporate Investments Pfizer Completes Acquisition of Seagen 12.12.2023 Corporate Financial Investments Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
March 2023
03.13.2023 Financial Investments Pfizer Invests $43 Billion to Battle Cancer
October 2022
10.05.2022 Financial Investments Pfizer Completes Acquisition of Global Blood Therapeutics 10.03.2022 Financial Finance Investments Pfizer Completes Acquisition of Biohaven Pharmaceuticals
August 2022
08.08.2022 Financial Investments Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
June 2022
06.28.2022 Financial Investments Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus 06.23.2022 Financial Investments Vaccines Valneva and Pfizer Announce Closing of Equity Investment 06.09.2022 Financial Investments Pfizer Completes Acquisition of ReViral 06.06.2022 Financial Covid-19 Investments Vaccines Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. 06.01.2022 Investments Pfizer Provides Update on Ownership Interest in Haleon
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.